IL93846A0 - Endothelial cell growth factor,methods of isolation and expression - Google Patents

Endothelial cell growth factor,methods of isolation and expression

Info

Publication number
IL93846A0
IL93846A0 IL93846A IL9384690A IL93846A0 IL 93846 A0 IL93846 A0 IL 93846A0 IL 93846 A IL93846 A IL 93846A IL 9384690 A IL9384690 A IL 9384690A IL 93846 A0 IL93846 A0 IL 93846A0
Authority
IL
Israel
Prior art keywords
growth factor
factor
isolation
expression
methods
Prior art date
Application number
IL93846A
Other languages
English (en)
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of IL93846A0 publication Critical patent/IL93846A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
IL93846A 1989-03-24 1990-03-22 Endothelial cell growth factor,methods of isolation and expression IL93846A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32818189A 1989-03-24 1989-03-24
US34616589A 1989-05-02 1989-05-02
US36023589A 1989-06-01 1989-06-01

Publications (1)

Publication Number Publication Date
IL93846A0 true IL93846A0 (en) 1990-12-23

Family

ID=27406587

Family Applications (1)

Application Number Title Priority Date Filing Date
IL93846A IL93846A0 (en) 1989-03-24 1990-03-22 Endothelial cell growth factor,methods of isolation and expression

Country Status (12)

Country Link
EP (1) EP0464155B1 (da)
JP (1) JP3549202B2 (da)
AT (1) ATE152626T1 (da)
AU (1) AU647737B2 (da)
CA (1) CA2050318C (da)
DE (1) DE69030660T2 (da)
DK (1) DK0464155T3 (da)
ES (1) ES2103740T3 (da)
IL (1) IL93846A0 (da)
NZ (1) NZ233067A (da)
PT (1) PT93560B (da)
WO (1) WO1990011084A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300791B2 (en) 1989-05-12 2007-11-27 Genentech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
CZ291047B6 (cs) * 1992-10-28 2002-12-11 Genentech, Inc. Farmaceutický prostředek obsahující antagonisty faktoru růstu vaskulárních endoteliálních buněk
CN1701814A (zh) * 1992-11-13 2005-11-30 马克斯普朗克科学促进协会 作为血管内皮生长因子受体的f1k－1
US7030083B2 (en) 1998-09-09 2006-04-18 University Of Washington Treatment of eclampsia and preeclampsia
EP1109571B1 (en) 1998-09-09 2004-03-03 Scios Inc. Methods of treating salt-dependent hypertension
US6783953B1 (en) 1998-12-22 2004-08-31 Janssen Pharmaceutica N.V. Vascular endothelial growth factor-X
US7026462B2 (en) 2000-12-07 2006-04-11 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456550A (en) * 1982-11-22 1984-06-26 President And Fellows Of Harvard College Vascular permeability factor
US5008196A (en) * 1987-08-21 1991-04-16 Monsanto Company Stimulation of endothelial cell growth
US5240848A (en) * 1988-11-21 1993-08-31 Monsanto Company Dna sequences encoding human vascular permeability factor having 189 amino acids
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
EP0399816B1 (en) * 1989-05-24 1995-12-20 Merck & Co. Inc. Purification and characterization of a glioma-derived growth factor
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor

Also Published As

Publication number Publication date
EP0464155A1 (en) 1992-01-08
ATE152626T1 (de) 1997-05-15
JPH04504262A (ja) 1992-07-30
EP0464155A4 (en) 1992-05-06
DE69030660T2 (de) 1997-09-25
CA2050318A1 (en) 1990-09-25
PT93560B (pt) 1996-08-30
JP3549202B2 (ja) 2004-08-04
ES2103740T3 (es) 1997-10-01
DE69030660D1 (de) 1997-06-12
AU5565990A (en) 1990-10-22
PT93560A (pt) 1990-11-07
NZ233067A (en) 1993-05-26
DK0464155T3 (da) 1997-11-17
AU647737B2 (en) 1994-03-31
CA2050318C (en) 2011-04-12
EP0464155B1 (en) 1997-05-07
WO1990011084A1 (en) 1990-10-04

Similar Documents

Publication Publication Date Title
CA2099138A1 (en) Chondroitinase, Process for Preparing the Same, and Pharmaceutical Composition Comprising the Same
AU4488689A (en) Osteogenic factors
IL93846A0 (en) Endothelial cell growth factor,methods of isolation and expression
AU6244490A (en) Vaccine against lyme disease
DK602387D0 (da) Fremgangsmaade til fremstilling af glucosaminer med lav molekylvaegt og anvendelse af saadanne glucosaminer
IT8220662A0 (it) Procedimento per l'ottenimento di mucopolisaccaridi biologicamente attivi, aventi purezza elevata, mediante depolimerizzazione controllata della eparina.
EP0092163A3 (en) Purified interleukin 2
FI923347A0 (fi) Blodfaktorer producerade med rekombinant-dna-teknik och foerfarande foer expression av naemnda blodfaktorer samt i naemnda foerfarande anvaenda rekombinanta kokoppvirus.
AU591772B2 (en) Substituted oxime-ethers and their use as bioregulators to lower the endogenous ethylene level in plants
FR2564106B1 (fr) Vecteurs d'expression du facteur ix, cellules transformees par ces vecteurs et procede de preparation du facteur ix.
ZA892744B (en) Method for the preparation of zeolites
EP0807685A3 (en) Sucrose phosphate synthase (sps), its process for preparation, its cdna and utilization of cdna to modify the expression if sps in the plant cells
CA2130618A1 (en) Stereoselective process for preparing .beta.-anomer enriched 2-deoxy-2,2-difluoro-d-ribofuranosyl-3,5-hydroxy protected-1-alkyl and aryl sulfonate intermediates
DK0385391T3 (da) Ekspressionsvektorer til syntese af proteiner i Schizosaccharomyces pombe
DE3278433D1 (de) Tubular pneumodynamic bearing
ES2121209T3 (es) Punta de corazon de cruzamiento.
DK486988D0 (da) Pyridylethanolaminer, deres fremstilling og laegemidler indeholdende forbindelserne
EP0258053A3 (en) Low wear polyarylate
SU674149A1 (ru) Устройство дл автоматического регулировани напр жени и компенсации реактивной мощности в узлах нагрузки
ES1008755U (es) Estructura mejorada de instalaciones correctoras de deformaciones en vehiculos.
Stathopoulos Erratum for “Wind Pressure Functions for Flat Roofs”
徐景星 et al. ANTITHROMBOTIC EFFECT 0F A FRACTION FR0M A. HALYS VENOM ON RABBIT
ES8606248A1 (es) Un procedimiento para la produccion de una dihidroxifenil- glicina opticamente activa
SU1568302A1 (ru) Держатель протеза клапана сердца
IT1243931B (it) Film polimerico modificato caratterizzato da elevata barriera all'ossigeno

Legal Events

Date Code Title Description
FF Patent granted
FF Patent granted
FF Patent granted
KB Patent renewed
RH Patent void
KB Patent renewed
KB Patent renewed
EXP Patent expired